Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Neratinib

Neratinib

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Neratinib

22 trials tracked of Neratinib: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 608 citations.

22Trials tracked
2Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 2 Phase 2 14 Phase 1 6
  1. Phase 3 A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting Completed · 608 cited
  2. Phase 3 Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer Completed
  3. Phase 2 Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer Completed
  4. Phase 2 Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer Completed
  5. Phase 2 A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer Completed
  6. Phase 2 Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer Completed
Show 16 more trials
  1. Phase 2 Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer Completed
  2. Phase 2 An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide Completed
  3. Phase 2 Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer Completed
  4. Phase 2 Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer Completed
  5. Phase 2 Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer Completed
  6. Phase 2 Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer Completed
  7. Phase 2 Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib Completed
  8. Phase 2 Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer Completed
  9. Phase 2 A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With Neratinib Completed
  10. Phase 2 Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer Completed
  11. Phase 1 Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid Tumors Completed
  12. Phase 1 A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor Completed
  13. Phase 1 Study Evaluating HKI-272 in Tumors Completed
  14. Phase 1 Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors Completed
  15. Phase 1 A Study Of The Safety And Tolerability Of HKI-272 Administered Orally To Japanese Subjects With Advanced Solid Tumors Completed
  16. Phase 1 Study Evaluating Safety And Tolerability, Solid Tumor Completed

Showing the 22 most-cited and recently-updated of 22 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.